Melissa is more fascinating in the field of aromatherapy, in fact, it is in the treatment of Alzheimer's disease. Scientists tested a variety of herb extracts and found that some of them combined well with acetylcholine receptors, it was one of them.
Scientific studies have found that there are two acetylcholine subjects in the human body. One is a toxic-alkali-alkali subject, which can produce side-sensing neuro-excitement effects, i.e. inhibition of heart activity, bronchial gastrointestinal smooth muscle and bladder forced urethra muscle contraction, increased digestive gland secretion, narrowing of pupils, etc. The other is a nicotine-alkali subject, which can cause post-sectional neuron excitement in autonomous nerve joints, or lead to skeletal muscle excitability.
The nicotine in the brains of alzheimer's patients gradually decreases over time, resulting in corresponding symptoms. Currently it is used in clinical drugs, they are to promote the role of acetylcholine, but it can not really cure the disease, only help patients delay the rate of memory loss.
It is worth noting that the binding of Melissa and nicotine receptors is particularly good, so major pharmaceutical companies are actively testing what kind of binding effect is produced. However, due to the complexity of the causes of Alzheimer's disease, Melissa and its derivatives may only target one of these mechanisms , it is may not necessarily cure other causes. For example, studies suggest that Alzheimer's disease may be linked to the astration of beta-amyloid proteins in the brain, which destroys tissue in the brain.
For Further Information, please contact: email@example.com